Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sorin SpA Announces Acquisition of Neurotech SA


Monday, 12 Nov 2012 09:22am EST 

Sorin SpA announced that it has acquired Neurotech SA, a developer of neurostimulation devices. The acquisition will accelerate the time to market of Sorin’s neuromodulation therapies to treat Heart Failure. Neurotech will also complement Sorin’s key Heart Failure treatment technical experience and enhance its intellectual property position. Financial details were not disclosed. Neurotech has experience in the development of implantable medical devices that stimulate the vagus nerve. Stimulation of the vagus nerve has shown promising clinical effects on the cardiovascular function in experimental and pilot clinical studies, and may become a potential treatment for heart failure. 

Company Quote

2.086
0.0040 +0.19%
11:06am EDT